Business Wire

QC Laboratories, Inc. Awarded Nadcap Certification for Computed Radiography

19.7.2023 14:59:00 EEST | Business Wire | Press release

Share

QC Laboratories, Inc., a leading nondestructive testing and inspection services company, has announced that it has been awarded Nadcap certification for computed radiography (AC7114/10S) by the Performance Review Institute (PRI).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230717661945/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Business Wire)

The Nadcap certification is a highly respected accreditation that recognizes companies that demonstrate exceptional quality and performance in the aerospace industry. QC Laboratories, Inc. has met the rigorous requirements of the Nadcap audit for computed radiography, which includes stringent technical and quality standards, as well as an assessment of the company's personnel, facilities, and processes.

"We are thrilled to have achieved this certification, which reflects our unwavering commitment to providing the highest quality nondestructive testing and inspection services to our customers," said Jose Crespo, General Manager of QC Laboratories, Inc. "With the addition of Nadcap certification for Computed Radiography per ASTM E2033, combined with our powerful 450kV x-ray system, we are better equipped to serve our Nadcap subscriber customers in aerospace & defense, space, and beyond."

Computed radiography is a nondestructive testing method that uses digital imaging technology to produce high-quality images of internal structures and components. This technology enables the detection of defects and discontinuities in materials, such as cracks, porosity, and inclusions, without damaging them.

QC Laboratories, Inc. has had remarkable success in identifying defects in metal additive manufacturing parts using computed radiography. The company has been able to detect defects as small as 25 microns, which is crucial for ensuring the quality and reliability of complex metal parts made from exotic and refractory metals like those used in aircraft and rocket engine components, where high strength and thermodynamics are required.

With the new Nadcap certification for computed radiography (AC7114/10S), QC Laboratories, Inc. is now able to offer computed radiography services that meet the rigorous quality and technical standards of the aerospace industry. This certification further strengthens the company's position as a trusted provider of nondestructive testing and inspection services to customers in a wide range of industries.

About QC Laboratories, Inc.

QC Laboratories, Inc. is a nondestructive testing laboratory in Hollywood, Florida, USA. The company was founded in 1965 and offers various testing services, including nondestructive testing (NDT), chemical processing, and consulting services.

QC Laboratories serves a variety of industries, including aerospace, additive manufacturing, automotive, defense, manufacturing, and consumer products. The laboratory is accredited by the American Society for Nondestructive Testing (ASNT) and is certified by the Federal Aviation Administration (FAA) and Nadcap (Performance Review Institute) for NDT services.

QC Laboratories has a team of experienced nondestructive engineers and technicians using advanced testing equipment and techniques to provide accurate and reliable results. The laboratory is committed to delivering high-quality services and maintaining the highest standards of professionalism and ethics.

For more information about QC Laboratories' new capability for pre-penetrant etching of metal AM parts, please visit www.qclabs.net or contact the laboratory directly.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Althea Lawson
QC Laboratories, Inc.
Phone: (954) 925-0499
Email: info@qclabs.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

European Commission Approves DAYBU ® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union24.8.2026 10:01:00 EEST | Press release

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older, making it the first and only treatment approved for Rett syndrome in the European Union (EU). “The approval of DAYBU marks a significant milestone for the Rett syndrome community in the EU and advances our mission to bring this innovative treatment to patients and families who have long faced a profound unmet medical need,” said Catherine Owen Adams, Acadia’s Chief Executive Officer. “For people living with Rett syndrome, a devastating rare neurodevelopmental disorder, there have been no approved treatment options in the EU. We are proud to make DAYBU available and look forward to supporting patients, caregivers, and healthcare providers gain access to treatment." The DAYBU marketing authorization in the EU is prim

ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 09:36:00 EEST | Press release

Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly as possible. “Our discovery of the first orexin agonist is a successful representation of Japan-originated science that will directly impact people around the world living with narcolepsy type 1,” said Julie Kim, president and chief executive officer of Takeda. “With the potential to redefine narcolepsy type 1 care, ORZEYFUL is the first validation of our broader orexin strategy, demonstrating how scientifi

Fasset Hits $1B Valuation as SBI Group Leads $68M Series C to Scale AI-Powered Stablecoin Neobanking24.8.2026 09:03:00 EEST | Press release

Fasset, the AI-powered stablecoin neobanking platform, today announced it has raised $68 million in Series C funding at a $1 billion valuation. The financing was led by SBI Group and follows Fasset’s $51 million Series B earlier this year, which brought Speedinvest onto the cap table alongside a group of strategic investors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823503947/en/ Mohammad Raafi Hossain, Co-Founder and CEO, Fasset The new capital will support the expansion of Own Network, Fasset’s regulated financial network that connects banks, telcos, payment and liquidity providers to enable settlement across international markets. Fasset will also increase investment in agentic AI-enabled systems supporting corridor banking, stablecoin settlement and tokenized asset infrastructure. After raising Series B in May, Fasset has now raised a total of $119 million in 2026. The financing marks Fasset’s entry into the glob

Zanders Expands DACH Region with New Office in Vienna, Austria24.8.2026 08:11:00 EEST | Press release

Zanders, the global treasury, risk, and technology consultancy, today announced a significant expansion of its DACH region with the opening of a new office in Vienna. The move builds on Zanders' continued growth across Germany, Austria, and Switzerland, and marks another step in the firm's strategy of deepening its presence in the markets where client demand for specialized treasury, risk, and corporate finance advisory is growing fastest. DACH has been one of Zanders' priority regions for several years, with the firm steadily expanding its team and client base across Germany and Switzerland. Austria represents a natural next step in that growth: in conversations with clients in the market, Zanders has seen growing interest in treasury transformation and financing support, as companies work through interest rate volatility, refinancing needs, and a broader shift toward more digitized, centralized treasury operations. The new Vienna office allows Zanders to be closer to clients' operati

Novotech Strengthens Presence in Japan with Opening of Tokyo Office24.8.2026 02:01:00 EEST | Press release

Novotech, a leading global biotech CRO and full-service clinical research organization, has strengthened its established presence in Japan with the opening of a new office in Tokyo. The investment builds on Novotech’s existing operations and clinical trial activity in Japan and further enhances its ability to support Japanese biopharma companies as they advance programs regionally and across key international markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823592174/en/ Takeshi Mori, Novotech Country Head, Japan The Tokyo office will serve as a strategic hub for Novotech’s growing operations in Japan, providing enhanced local expertise and strengthening collaboration with clients, partners, research institutions, and innovation ecosystems across the region. Novotech is currently supporting ongoing studies in Japan and provides sponsors with integrated support across early-phase clinical development in Australia, F

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye